Centrus Energy shares advanced after signing a letter of intent with Oklo to supply High-Assay Low-Enriched Uranium fuel for its Aurora Powerhouse small modular reactor programme, positioning Centrus as the critical domestic supply chain enabler for advanced nuclear deployments that require HALEU at a scale no other licensed US producer can currently provide.

Key Highlights

  • Centrus Energy advanced after signing a letter of intent with Oklo to supply HALEU fuel for the Aurora Powerhouse SMR programme, the latest in a series of commercial agreements validating its unique domestic production capability.
  • HALEU availability has been identified as the single most critical near-term constraint on the advanced nuclear deployment timeline, making Centrus's commercial agreements with reactor developers strategically important beyond their individual revenue contribution.
  • Each new LOI and commercial agreement strengthens the commercial justification for expanding HALEU production capacity, which would require significant capital investment and extended regulatory engagement to scale beyond current demonstration volumes.

Centrus Energy (NYSE: LEU) occupies a strategically unique position in the advanced nuclear supply chain: it is the only licensed producer of High-Assay Low-Enriched Uranium in the United States operating under a Department of Energy contract, a regulatory and technical status that took years to establish and cannot be quickly replicated by new entrants. This scarcity value makes every commercial agreement with a reactor developer a validation event that reinforces both the near-term revenue thesis and the long-term capacity expansion investment case.

The Oklo Aurora Powerhouse programme is one of the more commercially advanced SMR projects in the US pipeline, having received regulatory engagement from the Nuclear Regulatory Commission. Its HALEU requirement connects directly to Centrus's production capability, making the LOI a commercial relationship with concrete near-term supply implications rather than a speculative future option.

The broader significance of the Centrus-Oklo agreement extends to the advanced nuclear financing landscape. Investors and government bodies considering capital commitments to HALEU production expansion need evidence that commercial demand is real and contracted. Each LOI adds to that evidence base, incrementally de-risking the investment case for the production capacity build-out that the sector ultimately requires.